Bone and Mineral Metabolism Disorders

Top Story

AMBER: Patiromer enables persistent spironolactone treatment in patients with hypertension, CKD

AMBER: Patiromer enables persistent spironolactone treatment in patients with hypertension, CKD
September 16, 2019
In the Journals

Levels of mineral and bone disorder markers vary among race and country

August 14, 2019
Researchers found differences for levels of parathyroid hormone, calcium and phosphorus in the first 5 years of hemodialysis based on patient race and country of…
Cover Story

Consider a step therapy approach for the treatment of hyperparathyroidism and mineral and bone disorder in patients on dialysis

Nephrology News & Issues, July 2019
George R. Aronoff, MD, MS, FACP, FASN
Managing the cascade of illness triggered by the imbalance of calcium and phosphorus challenges physicians who care for patients with CKD. Delineated in this article is…
Meeting News

Hyperkalemia may increase mortality in solid organ transplant recipients

November 21, 2018
Solid organ transplant recipients who develop hyperkalemia have an increased risk of mortality and 30-day readmissions, according to results presented at ASN Kidney Week…
More Headlines »

Preventing Medical Errors for Clinical Health Professionals

No commercial support for this activity.

This educational monograph addresses the identification, reporting, monitoring and reduction of medical error. It is…
More »
Original ResearchOpen Access

Perception Versus Reality: The Use of Teach Back by Medical Residents

HLRP: Health Literacy Research and Practice, Spring 2019, Volume 3 Issue 2
Health care providers (HCPs) may ask patients if they understand their diagnosis or instructions during clinic visits;…
More »

X-linked Hypophosphatemia: Integrating New Evidence to Optimize Diagnosis and Treatment

This activity is supported by an educational grant from Ultragenyx.

X-linked hypophosphatemia (XLH) is a rare hereditary form of non-nutritional rickets that does not respond to vitamin D…
More »